Clinical Trial Update: BIIB033 In Acute Optic Neuritis (AON) [Phase 2]

View source ↗

Summary

Biogen's BIIB033 Phase 2 trial in acute optic neuritis has completed and its results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• BIIB033

Snippet

Sponsor: Biogen | Conditions: Acute Optic Neuritis | Phase 2 | Status: COMPLETED | Results posted: 2016-06-30